Human Models of Selective Insulin Resistance: Alpelisib, Part I
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Recruiting · NCT06354088 · Registry updated 2026-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Human Models of Selective Insulin Resistance: Alpelisib, Part I | Body Weight, Digestive System Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, prediabetes syndrome | Recruiting | Phase 1 | 2026-08-24 | NCT06354088 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Columbia University | 375 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
| Stanford University | 620 |
| University of California, Berkeley | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Irving Medical Center | New York | United States | 234 |